BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26290130)

  • 1. Protective efficacy of stockpiled vaccine against H5N8 highly pathogenic avian influenza virus isolated from a chicken in Kumamoto prefecture, Japan, in 2014.
    Gamoh K; Nakamizo M; Okamatsu M; Sakoda Y; Kida H; Suzuki S
    J Vet Med Sci; 2016 Jan; 78(1):139-42. PubMed ID: 26290130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
    Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection Afforded by a Recombinant Turkey Herpesvirus-H5 Vaccine Against the 2014 European Highly Pathogenic H5N8 Avian Influenza Strain.
    Steensels M; Rauw F; van den Berg T; Marché S; Gardin Y; Palya V; Lambrecht B
    Avian Dis; 2016 May; 60(1 Suppl):202-9. PubMed ID: 27309056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
    Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
    Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency of an inactivated influenza vaccine prepared from a non-pathogenic H5N1 virus against a challenge with antigenically drifted highly pathogenic avian influenza viruses in chickens.
    Shichinohe S; Okamatsu M; Yamamoto N; Noda Y; Nomoto Y; Honda T; Takikawa N; Sakoda Y; Kida H
    Vet Microbiol; 2013 May; 164(1-2):39-45. PubMed ID: 23462521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection.
    Yuk SS; Erdene-Ochir TO; Kwon JH; Noh JY; Hong WT; Jeong JH; Jeong S; Gwon GB; Shin JI; Sur JH; Song CS
    Vaccine; 2017 Mar; 35(9):1316-1322. PubMed ID: 28169074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an H5N8 influenza A virus isolated from chickens during an outbreak of severe avian influenza in Japan in April 2014.
    Kanehira K; Uchida Y; Takemae N; Hikono H; Tsunekuni R; Saito T
    Arch Virol; 2015 Jul; 160(7):1629-43. PubMed ID: 25902725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpesvirus of turkey-vectored avian influenza vaccine offers cross-protection against antigenically drifted H5Nx highly pathogenic avian influenza virus strains.
    Nassif S; Zaki F; Mourad A; Fouad E; Saad A; Setta A; Felföldi B; Mató T; Kiss I; Palya V
    Avian Pathol; 2020 Dec; 49(6):547-556. PubMed ID: 32615785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy of an inactivated chimeric H7/H5 avian influenza vaccine against highly pathogenic avian influenza H7N9 and clade 2.3.4.4 H5 viruses.
    Peng C; Hou G; Li J; Wang S; Wang Y; Cheng S; Yu X; Jin J; Jiang W
    Vet Microbiol; 2018 Sep; 223():21-26. PubMed ID: 30173747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia.
    Isoda N; Sakoda Y; Kishida N; Soda K; Sakabe S; Sakamoto R; Imamura T; Sakaguchi M; Sasaki T; Kokumai N; Ohgitani T; Saijo K; Sawata A; Hagiwara J; Lin Z; Kida H
    Arch Virol; 2008; 153(9):1685-92. PubMed ID: 18651092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of an inactivated chimeric H5 avian influenza vaccine against H5 highly pathogenic avian influenza virus clades 2.3.4.4 and 2.3.2.1.
    Li J; Hou G; Wang Y; Wang S; Cheng S; Peng C; Jiang W
    J Gen Virol; 2018 Dec; 99(12):1600-1607. PubMed ID: 30358528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Efficacy of the Inactivated H5N1 Influenza Vaccine Re-6 Against Different Clades of H5N1 Viruses Isolated in China and the Democratic People's Republic of Korea.
    Zeng X; Deng G; Liu L; Li Y; Shi J; Chen P; Feng H; Liu J; Guo X; Mao S; Yang F; Chen Z; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):238-40. PubMed ID: 27309061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus.
    Sasaki T; Kokumai N; Ohgitani T; Sakamoto R; Takikawa N; Lin Z; Okamatsu M; Sakoda Y; Kida H
    Vaccine; 2009 Aug; 27(38):5174-7. PubMed ID: 19596414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy.
    Park JK; Lee DH; Youn HN; Kim MS; Lee YN; Yuk SS; Lim TH; Jang JH; Kwon JH; Kim BY; Kang SM; Seong BL; Lee JB; Park SY; Choi IS; Song CS
    Influenza Other Respir Viruses; 2013 May; 7(3):340-8. PubMed ID: 22716302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental and Field Results Regarding Immunity Induced by a Recombinant Turkey Herpesvirus H5 Vector Vaccine Against H5N1 and Other H5 Highly Pathogenic Avian Influenza Virus Challenges.
    Gardin Y; Palya V; Dorsey KM; El-Attrache J; Bonfante F; Wit Sd; Kapczynski D; Kilany WH; Rauw F; Steensels M; Soejoedono RD
    Avian Dis; 2016 May; 60(1 Suppl):232-7. PubMed ID: 27309060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of an update system for vaccine strains of veterinary influenza vaccines in Japan.
    Gamoh K; Nakamura S
    Biologicals; 2015 Mar; 43(2):150-2. PubMed ID: 25614371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of the protective efficacy of two avian influenza H5 vaccines against clade 2.3.4.4b H5N8 highly pathogenic avian influenza virus in commercial broilers.
    El-Shall NA; Awad AM; Sedeik ME
    Res Vet Sci; 2021 Nov; 140():125-133. PubMed ID: 34425414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
    Peeters B; Reemers S; Dortmans J; de Vries E; de Jong M; van de Zande S; Rottier PJM; de Haan CAM
    Virology; 2017 Mar; 503():83-93. PubMed ID: 28135661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.
    Grund C; Abdelwhab el-SM; Arafa AS; Ziller M; Hassan MK; Aly MM; Hafez HM; Harder TC; Beer M
    Vaccine; 2011 Jul; 29(33):5567-73. PubMed ID: 21244859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.